Sep 30

Scientific

SS 32 - CNS 2: Gliomas: Survivorship and Clinical Trials

Room 310-312

08:00am - 09:00am PT

Central Nervous System

MODERATOR(S)

Steve Braunstein, MD, PhD - University of California, San Francisco

Kelli Pointer, MD, PhD - Dartmouth Cancer Center

Credits

AMA PRA Category 1 Credits:	1.00
CAMPEP Credits:	1.00
MDCB Credits:	1.00

Presentations

08:00am - 08:10am PT

Cognitive Function and Quality of Life in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II Study

Speaker: Jason Slater, MD - Department of Radiation Medicine, Loma Linda University, Loma Linda
08:10am - 08:20am PT

WF-1801: Cognitive Outcomes of a Single Arm Pilot Study of Ramipril for Prevention of Radiation-Induced Cognitive Decline in Glioblastoma Patients Receiving Chemoradiotherapy

Speaker: Amanda Goetz, MD, MS - Atrium Health Wake Forest Baptist, Lexington
08:20am - 08:30am PT

Validating the FACT-Br Cognitive Index for Early Detection of Radiation-Induced Cognitive Decline in Primary Brain Tumors

Speaker: Ariana Chirban, MD, BS - UC San Diego School of Medicine, La Jolla
08:30am - 08:40am PT

Predictive Factors for Survival after Reirradiation of IDH Wild Type High Grade Glioma

Speaker: John Petersen, DO - Wake Forest Baptist Medical Center, Winston Salem
08:40am - 08:50am PT

Comparing the Effectiveness of Hypofractionated Radiotherapy with Conventional Radiotherapy in High Grade Glioma Treatment: An Open Labelled Randomized Controlled Trial in a Tertiary Care Center in Central India

Speaker: . Simran, MBBS - All India Institute of Medical Sciences, Raipur, C.G, Raipur
08:50am - 09:00am PT

Discussant

Speaker: Michelle Kim, MD - University of Michigan, Ann Arbor